Bristol-Myers Directors Sued in NY Over FCPA Inaction
By Martin O'Sullivan ( August 8, 2016, 3:31 PM EDT) -- An investor has launched a derivative suit in New York alleging that directors of Bristol-Myers Squibb Co. failed to respond to warning signs that its representatives in China were bribing state-owned and state-controlled hospitals to boost prescription sales....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.